ARCHIVES

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

This article is from The Cancer Letter archive.

Vol. 27 No. 13 | March 30, 2001

Download PDF Visit The Full Archive

Related Articles

In the Cancer Centers: Margaret Kripke of M.D. Anderson to Retire in 2007.

June 16, 2006

NIAID Advisors Ok Recompetition of Pediatric ACTGs

February 14, 1992

2013 Appropriations: Additional Level of Grant Review Proposed As NIH Prepares For Cost Cutting

March 30, 2012

Bristol To Support Grants For Studies On Drug Resistance

June 26, 1987

Funding Opportunities Listed.

January 21, 2005

Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials.

October 15, 2004